BLTE Message Board Post 10053840 | null
home / stock / blte / blte message board
khamalian
(investorshub)
Posted on: Aug/02/2022 15:15:17
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169562449
'Novel Approach For Retinal Disease Needs' Stock Belite
News, Short Squeeze, Breakout and More Instantly...
-
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) Data from a 24-month Phase 2 trial in adolescent STGD1 ...
-
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive ma...
-
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) Data from a 24-month Phase 2 trial in adolescen...